Press Releases


Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote "FOR" Merger Agreement with Cigna


Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote "FOR" Merger with Cigna


Express Scripts Announces New Recommendations Tackling High Drug Prices


Express Scripts Announces 2018 Second Quarter Results


Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis


Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details

View all Press Releases

Media Inquiries

Brian Henry Vice President, Corporate Communications 314.684.6438 |

Phil Blando Senior Director, Corporate Communications 202.383.7982 |

Jennifer Luddy Director, Corporate Communications 201.269.6402 |

Media Resources

Express Scripts grants a limited, non-transferrable license to use the images and video content on this page (“Press Materials”) in connection with editorial usage by accredited members of the press, or other industry analysis reporting about Express Scripts. All other uses of the Press Materials are subject to prior written permission by Express Scripts. Press Materials may not be used for any personal or commercial use, or in any way that would be likely to create confusion as to whether Express Scripts is endorsing or sponsoring the usage. Press Materials may not be modified or changed in any way (other than, with respect to photos, for resizing and with respect to video material, to accompany news reporting as indicated above). By downloading and otherwise using the Press Materials, you acknowledge and agree to these terms, and to all other applicable terms and conditions associated with this website.

Download our Corporate Overview

Corp Overview

Download Images

Express Scripts Headquarters thumbnail

Express Scripts Lab Exterior thumbnail Express Scripts Lab Interior 2 thumbnail
 Express Scripts Pharmacist thumbnail Express Scripts Pharmacy thumbnail 
Flying E

Download B-roll